Postoperative adjuvant chemotherapy of gastric cancer: Scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials

Hei Cheul Jeung, SunYoung Rha, Sang Joon Shin, Joong Bae Ahn, Jae Kyung Roh, Chan Hee Park, Sung Hoon Noh, Hyuncheol Chung

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to scrutinize the evidence of adjuvant chemotherapy of gastric cancer by assessing the quality of the medical literature of randomized controlled trials (RCTs). A quality assessment (QA) scoring system was devised with the three parameters-control of bias, quality of report, and quality of design-which consisted 19 items. We searched for all the publications of the RCTs, from 1969 to 2007, with surgery-only arm, and their associated meta-analyses to score. Among the 26 RCTs, quality of three articles were graded as (2+), 10 articles as (1+), and 13 articles as (-). Recently published studies had overall better quality of report, but not necessarily better quality of design. Three studies demonstrating a positive survival benefit of adjuvant chemotherapy had a grade (1+). Hierarchical clustering revealed that the 26 articles were grouped into three major branches associated with study quality and a multi-institutional setting. We also obtained a statistically significant set of ten items (P < 0.001) that could differentiate articles of good (1-2+) and low quality (-) through supervised two-way hierarchical clustering. Finally, the level of recommendation for adjuvant chemotherapy in gastric cancer was to be a "B" according to the Scottish Intercollegiate Guidelines Network (SIGN) System. QA of medical literature should be an essential consideration for medical-related decision-making and the formation of evidence-based guidelines. Multidisciplinary discussion to develop and refine trial design is important for procuring better quality of RCTs of adjuvant chemotherapy of gastric cancer.

Original languageEnglish
Pages (from-to)919-927
Number of pages9
JournalCancer Chemotherapy and Pharmacology
Volume63
Issue number5
DOIs
Publication statusPublished - 2009 Apr 1

Fingerprint

Chemotherapy
Adjuvant Chemotherapy
Stomach Neoplasms
Randomized Controlled Trials
Cluster Analysis
Guidelines
Quality Control
Surgery
Publications
Meta-Analysis
Decision making

All Science Journal Classification (ASJC) codes

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Cite this

@article{0aa0d593c89f43ba8e9811175637f985,
title = "Postoperative adjuvant chemotherapy of gastric cancer: Scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials",
abstract = "The aim of this study was to scrutinize the evidence of adjuvant chemotherapy of gastric cancer by assessing the quality of the medical literature of randomized controlled trials (RCTs). A quality assessment (QA) scoring system was devised with the three parameters-control of bias, quality of report, and quality of design-which consisted 19 items. We searched for all the publications of the RCTs, from 1969 to 2007, with surgery-only arm, and their associated meta-analyses to score. Among the 26 RCTs, quality of three articles were graded as (2+), 10 articles as (1+), and 13 articles as (-). Recently published studies had overall better quality of report, but not necessarily better quality of design. Three studies demonstrating a positive survival benefit of adjuvant chemotherapy had a grade (1+). Hierarchical clustering revealed that the 26 articles were grouped into three major branches associated with study quality and a multi-institutional setting. We also obtained a statistically significant set of ten items (P < 0.001) that could differentiate articles of good (1-2+) and low quality (-) through supervised two-way hierarchical clustering. Finally, the level of recommendation for adjuvant chemotherapy in gastric cancer was to be a {"}B{"} according to the Scottish Intercollegiate Guidelines Network (SIGN) System. QA of medical literature should be an essential consideration for medical-related decision-making and the formation of evidence-based guidelines. Multidisciplinary discussion to develop and refine trial design is important for procuring better quality of RCTs of adjuvant chemotherapy of gastric cancer.",
author = "Jeung, {Hei Cheul} and SunYoung Rha and Shin, {Sang Joon} and Ahn, {Joong Bae} and Roh, {Jae Kyung} and Park, {Chan Hee} and Noh, {Sung Hoon} and Hyuncheol Chung",
year = "2009",
month = "4",
day = "1",
doi = "10.1007/s00280-008-0808-5",
language = "English",
volume = "63",
pages = "919--927",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "5",

}

Postoperative adjuvant chemotherapy of gastric cancer : Scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials. / Jeung, Hei Cheul; Rha, SunYoung; Shin, Sang Joon; Ahn, Joong Bae; Roh, Jae Kyung; Park, Chan Hee; Noh, Sung Hoon; Chung, Hyuncheol.

In: Cancer Chemotherapy and Pharmacology, Vol. 63, No. 5, 01.04.2009, p. 919-927.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Postoperative adjuvant chemotherapy of gastric cancer

T2 - Scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials

AU - Jeung, Hei Cheul

AU - Rha, SunYoung

AU - Shin, Sang Joon

AU - Ahn, Joong Bae

AU - Roh, Jae Kyung

AU - Park, Chan Hee

AU - Noh, Sung Hoon

AU - Chung, Hyuncheol

PY - 2009/4/1

Y1 - 2009/4/1

N2 - The aim of this study was to scrutinize the evidence of adjuvant chemotherapy of gastric cancer by assessing the quality of the medical literature of randomized controlled trials (RCTs). A quality assessment (QA) scoring system was devised with the three parameters-control of bias, quality of report, and quality of design-which consisted 19 items. We searched for all the publications of the RCTs, from 1969 to 2007, with surgery-only arm, and their associated meta-analyses to score. Among the 26 RCTs, quality of three articles were graded as (2+), 10 articles as (1+), and 13 articles as (-). Recently published studies had overall better quality of report, but not necessarily better quality of design. Three studies demonstrating a positive survival benefit of adjuvant chemotherapy had a grade (1+). Hierarchical clustering revealed that the 26 articles were grouped into three major branches associated with study quality and a multi-institutional setting. We also obtained a statistically significant set of ten items (P < 0.001) that could differentiate articles of good (1-2+) and low quality (-) through supervised two-way hierarchical clustering. Finally, the level of recommendation for adjuvant chemotherapy in gastric cancer was to be a "B" according to the Scottish Intercollegiate Guidelines Network (SIGN) System. QA of medical literature should be an essential consideration for medical-related decision-making and the formation of evidence-based guidelines. Multidisciplinary discussion to develop and refine trial design is important for procuring better quality of RCTs of adjuvant chemotherapy of gastric cancer.

AB - The aim of this study was to scrutinize the evidence of adjuvant chemotherapy of gastric cancer by assessing the quality of the medical literature of randomized controlled trials (RCTs). A quality assessment (QA) scoring system was devised with the three parameters-control of bias, quality of report, and quality of design-which consisted 19 items. We searched for all the publications of the RCTs, from 1969 to 2007, with surgery-only arm, and their associated meta-analyses to score. Among the 26 RCTs, quality of three articles were graded as (2+), 10 articles as (1+), and 13 articles as (-). Recently published studies had overall better quality of report, but not necessarily better quality of design. Three studies demonstrating a positive survival benefit of adjuvant chemotherapy had a grade (1+). Hierarchical clustering revealed that the 26 articles were grouped into three major branches associated with study quality and a multi-institutional setting. We also obtained a statistically significant set of ten items (P < 0.001) that could differentiate articles of good (1-2+) and low quality (-) through supervised two-way hierarchical clustering. Finally, the level of recommendation for adjuvant chemotherapy in gastric cancer was to be a "B" according to the Scottish Intercollegiate Guidelines Network (SIGN) System. QA of medical literature should be an essential consideration for medical-related decision-making and the formation of evidence-based guidelines. Multidisciplinary discussion to develop and refine trial design is important for procuring better quality of RCTs of adjuvant chemotherapy of gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=61449156344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449156344&partnerID=8YFLogxK

U2 - 10.1007/s00280-008-0808-5

DO - 10.1007/s00280-008-0808-5

M3 - Article

C2 - 18712389

AN - SCOPUS:61449156344

VL - 63

SP - 919

EP - 927

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 5

ER -